Neos Therapeutics, Inc. total revenue, net income and dynamics of changes in US dollar today
Net revenue Neos Therapeutics, Inc. is now 17 540 000 $. Information about net revenue is taken from open sources. The dynamics of Neos Therapeutics, Inc. net income went up. The change was 1 712 000 $. Net income, revenue and dynamics - the main financial indicators of Neos Therapeutics, Inc.. Neos Therapeutics, Inc. online financial report chart. The financial report chart shows the values from 30/06/2017 to 30/09/2019. Neos Therapeutics, Inc. financial report on a graph in real time displays the dynamics, i.e. change in fixed assets of the company.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
30/09/2019
17 540 000 $
+40.29 % ↑
-2 051 000 $
-
30/06/2019
15 643 000 $
+37.67 % ↑
-3 763 000 $
-
31/03/2019
14 634 000 $
+36.4 % ↑
-7 600 000 $
-
31/12/2018
15 393 000 $
+97.68 % ↑
-9 337 000 $
-
30/09/2018
12 503 000 $
-
-12 695 000 $
-
30/06/2018
11 363 000 $
-
-15 207 000 $
-
31/03/2018
10 729 000 $
-
-14 436 000 $
-
31/12/2017
7 787 000 $
-
-14 224 000 $
-
30/09/2017
6 695 000 $
-
-16 258 000 $
-
30/06/2017
4 909 000 $
-
-18 674 000 $
-
Show:
to
Neos Therapeutics, Inc. financial report charts
Dates of Neos Therapeutics, Inc. finance reports: 30/06/2017, 30/06/2019, 30/09/2019. The dates of the financial statements are determined by the accounting rules. The latest financial report of Neos Therapeutics, Inc. is available online for such a date - 30/09/2019. Gross profit Neos Therapeutics, Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Neos Therapeutics, Inc. is 11 093 000 $
Neos Therapeutics, Inc. quarterly report dates
Cost of revenue Neos Therapeutics, Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Neos Therapeutics, Inc. is 6 447 000 $ Total revenue Neos Therapeutics, Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Neos Therapeutics, Inc. is 17 540 000 $ Operating revenue Neos Therapeutics, Inc. is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides. Operating revenue Neos Therapeutics, Inc. is 17 540 000 $
Operating income Neos Therapeutics, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Neos Therapeutics, Inc. is -433 000 $ Net income Neos Therapeutics, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Neos Therapeutics, Inc. is -2 051 000 $ Current assets Neos Therapeutics, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Neos Therapeutics, Inc. is 67 586 000 $
30/09/2019
30/06/2019
31/03/2019
31/12/2018
30/09/2018
30/06/2018
31/03/2018
31/12/2017
30/09/2017
30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
11 093 000 $
10 544 000 $
8 238 000 $
7 630 000 $
5 546 000 $
4 376 000 $
5 508 000 $
5 009 000 $
4 273 000 $
2 333 000 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
6 447 000 $
5 099 000 $
6 396 000 $
7 763 000 $
6 957 000 $
6 987 000 $
5 221 000 $
2 778 000 $
2 422 000 $
2 576 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
17 540 000 $
15 643 000 $
14 634 000 $
15 393 000 $
12 503 000 $
11 363 000 $
10 729 000 $
7 787 000 $
6 695 000 $
4 909 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
17 540 000 $
15 643 000 $
14 634 000 $
15 393 000 $
12 503 000 $
11 363 000 $
10 729 000 $
7 787 000 $
6 695 000 $
4 909 000 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-433 000 $
-2 446 000 $
-5 821 000 $
-7 236 000 $
-10 474 000 $
-13 267 000 $
-12 518 000 $
-11 665 000 $
-14 013 000 $
-16 381 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-2 051 000 $
-3 763 000 $
-7 600 000 $
-9 337 000 $
-12 695 000 $
-15 207 000 $
-14 436 000 $
-14 224 000 $
-16 258 000 $
-18 674 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
1 551 000 $
2 009 000 $
3 197 000 $
2 399 000 $
2 037 000 $
2 381 000 $
1 691 000 $
1 784 000 $
1 757 000 $
3 692 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
17 973 000 $
18 089 000 $
20 455 000 $
22 629 000 $
22 977 000 $
24 630 000 $
18 026 000 $
16 674 000 $
18 286 000 $
18 714 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
67 586 000 $
64 580 000 $
77 018 000 $
88 678 000 $
50 042 000 $
60 066 000 $
73 103 000 $
82 640 000 $
87 928 000 $
93 061 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
91 755 000 $
89 258 000 $
102 096 000 $
111 357 000 $
73 280 000 $
83 992 000 $
97 356 000 $
107 353 000 $
113 182 000 $
118 348 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
23 284 000 $
25 757 000 $
32 760 000 $
46 478 000 $
16 555 000 $
18 318 000 $
24 777 000 $
31 969 000 $
43 398 000 $
57 362 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
61 142 000 $
57 218 000 $
51 856 000 $
57 105 000 $
53 469 000 $
56 171 000 $
948 000 $
896 000 $
6 949 000 $
7 022 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
37 221 000 $
50 417 000 $
66 487 000 $
78 624 000 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
94 783 000 $
90 870 000 $
100 968 000 $
103 512 000 $
99 917 000 $
102 628 000 $
59 921 000 $
59 834 000 $
65 919 000 $
66 023 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
103.30 %
101.81 %
98.90 %
92.96 %
136.35 %
122.19 %
61.55 %
55.74 %
58.24 %
55.79 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
-3 028 000 $
-1 612 000 $
1 128 000 $
7 845 000 $
-26 637 000 $
-18 636 000 $
-4 519 000 $
7 890 000 $
14 700 000 $
25 316 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-4 159 000 $
-1 757 000 $
-6 103 000 $
-5 259 000 $
-14 985 000 $
-8 493 000 $
-12 704 000 $
-15 069 000 $
-15 937 000 $
-6 316 000 $
Last revenue report of Neos Therapeutics, Inc. was 30/09/2019. According to last financial report total revenue in Neos Therapeutics, Inc. was 17 540 000 US dollar and changed by +40.29% since last year. Net income in Neos Therapeutics, Inc. was -2 051 000 $ in last quartal, net income changes to 0%.
Total assets Neos Therapeutics, Inc. refers to the total amount of assets owned by a person or entity. Total assets Neos Therapeutics, Inc. is 91 755 000 $ Current cash Neos Therapeutics, Inc. - the sum of all of the cash a company has on the date of report. Current cash Neos Therapeutics, Inc. is 23 284 000 $ Current debt Neos Therapeutics, Inc. is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital. Current debt Neos Therapeutics, Inc. is 61 142 000 $
Neos Therapeutics, Inc. stocks data
NEOS stock price
Neos Therapeutics, Inc. stock price today, NEOS stock quote.
